Scroll To Top
Search by Speciality

European Society for Medical Oncology (ESMO) Sarcoma and Gastrointestinal Stromal Tumor (GIST) Symposium 2018

Milan Marriott Hotel # | Milano, ITALY
From 180 to 440 USD
Event Preview
This event
is Finished
Title: European Society for Medical Oncology (ESMO) Sarcoma and Gastrointestinal Stromal Tumor (GIST) Symposium 2018
Specialty: Radiation Oncology
Dates: From Feb, 5, 2018 to Feb, 7, 2018
Location: Milano, ITALY
Type: Symposium
Registration Cost: From 180 to 440 USD
Event Tools
  • Add to Favorites
  • Claim this event
Add to my Calendar
  • Scientific Programm
  • Online registration
  • Exhibition floorplans
  • Sponsorship &
    Exhibition consensus
  • Virtual Booths
Weather Info (monthly averages) Max Temperature: C / F Min Temperature: C / F The above data in our Weather Info table are temperature predictions for the date of the medical event for Milano, Italy.
General Info
Event Venue:

Milan Marriott Hotel #

Milano, ITALY
Nestled in the heart of the city, the Milan Marriott Hotel is a stylish destination for both business and leisure travellers providing convenient access to many of the area's most prominent destinations. Ideal for those attending events at the Milan Fair exhibition hall and inside the city centre, this hotel in Milan, Italy also allows guests easy access to popular shopping malls, museums, historical sites and other local attractions. Situated near the trendy Navigli district where interesting studios and shops, wine bars and vibrant restaurants allow guests to discover the inviting flavors and sophisticated styles of the city, this distinctive hotel in Milan is also close to Cenacolo Vinciano, where Leonardo Da Vinci's famous masterpiece, "The Last Supper" is on display and just 15 minutes from San Siro Stadium. The hotel's central location and state-of-the-art event venues make it an ideal choice for hosting business meetings, conventions and elegant social gatherings in Milan, Italy. 22 meeting rooms 24,757 sq ft of total meeting space Meeting space with highest maximum capacity is Washington with a capacity of 1,400 Maximum of 12 breakout meeting room(s) Exhibition space on-site
Visit the Venue to read more
Concerned Audience:
  • Medical_Professionals
  • Medical_students
  • Nurses
Event Overview
Welcome message:

ESMO’s Sarcoma & GIST Symposium is a niche meeting which attracts the most brilliant medical minds working on these disease types today. The Symposium is known as an excellent place for international networking and collaboration, featuring discussions with the key opinion leaders in these rare sub-entities.

The aim of the Symposium is to bring the translational researchers and clinicians together in an integrated approach for better patient outcome.

ESMO invites you to join us in Milan!

ESMO Preceptorship course

Prior to the Sarcoma & GIST Symposium, ESMO will run a one-day course, 5 February, led by an expert faculty, designed to provide young oncologists with a brief outline of both STS & GIST. This course could be a first contact with these diseases for oncologists who are interested in knowing more and need an introduction prior to attending the higher-level conference in the two days following.

ESMO Advanced Sarcoma course

Also prior to the Sarcoma & GIST Symposium, ESMO will run an Advanced Sarcoma Course. This is a one-day event offering an intensive discussion of a set of clinical cases of STS & GIST for professionals who are already familiar with these diseases. Attendees will benefit from discussions about challenging clinical cases with specialists from both the EU and U.S.A., leveraging the different perspectives and expertise across continents. This course is the ideal preparation for clinicians joining the Sarcoma & GIST Symposium, 5-7 February.

Target audience

Medical oncologists

Surgical oncologists



Registration Needs updating Register Now
General Info:

The ESMO Secretariat must receive one completed registration per participant and the corresponding payment in Euro by the given deadlines. Please note that Registration per day is neither possible through the pre-registration procedure nor on-site.



Registration Cost
Early Registration

Late Registration From: 2017-11-11 To: 0--
On site Registration
Non member
Fee ESMO member

Group Registrations:

Group registrations not allowed

Accompanying Persons:

Accompanying persons not allowed

Registration Documents:
Letter of invitation:
We don’t provide letter of invitation
Letter of confirmation:
We don’t provide Letter of Confirmation
Proof of professional / educational status:
We don’t need Proof of professional/educational status
Online Abstract Submission:

We don’t accept Online Abstracts


Marriott Hotel

via Washington, 66 

Milan, 20146 Italy

Scientific Content Up to Date
Submission Info
Sponsors Exhibitors
General Info

Contact No.: +41 (0)91 973 19 47


Sponsors / Supporters


Lilly Oncology Logo

For more than 50 years, Lilly has been dedicated to delivering life-changing medicines and support to people living with cancer and those who care for them. Lilly is determined to build on this heritage and continue making life better for all those affected by cancer around the world. To learn more about Lilly’s commitment to people with cancer, please visit

Bronze Sponsors

Pfizer Oncology


Pfizer Oncology is committed to pursuing innovative treatments that are helping to redefine life with cancer. As an oncology leader with one of the most robust oncology pipelines in the industry, we are focused on translating scientific breakthroughs into clinical application. Additionally, we are dedicated to working collaboratively with the community to make a positive impact on people’s lives.

Supporter Sponsors


Bayer logo 2017

Bayer is committed to delivering Science For A Better Life by advancing a portfolio of innovative treatments. The oncology franchise at Bayer currently includes four oncology products in eight indications. Several other compounds are in various stages of clinical development, with the focus on potential first-in-class approaches across the areas of novel oncogenic signaling in combination with an effective biomarker strategy, antibody drug conjugates including a thorium platform and immuno-oncology.



PharmaMar is a global biopharmaceutical company, focused on oncology and committed to research and development. PharmaMar’s Yondelis® was the first antitumor drug of marine origin to be approved for commercialization, specifically to treat soft tissue sarcoma. It has obtained approval for treating ovarian cancer in the European Union. It is available in the main oncology markets: the US, Europe and Japan.

Premium Educational Grant Supporter

Loxo Oncology

Loxo Logo

Loxo Oncology is dedicated to developing highly selective medicines for patients with genetically defined cancers. We base our approach on two scientific trends: the increasing use of genetic testing in cancer clinical medicine and improving chemistry approaches to building highly selective inhibitors against single targets in the cancer cell.

Organising Agency

Contact No.: +41 (0)91 973 19 47


Event map
Revelant Events